FDA Import Refusal 1FX-5850225-4/10001/1 — Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company

Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company — FEI 1719513

The FDA refused shipment 1FX-5850225-4/10001/1 from Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company (United States) on Oct 2, 2026. The refused product falls under Drugs and Biologics — CARBAMIDE PEROXIDE (SOL) (ANTI-INFECTIVE, TOPICAL). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.